TrialHepatology (Baltimore, Md.)2026

A randomized, double-blind, phase 3, non-inferiority trial of pradefovir mesylate versus tenofovir disoproxil fumarate in Chinese patients with chronic hepatitis B.

Yanhang Gao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.